What changed
$DE — AVOID 📊 | 6 MONTHS THESIS
🎯 FQ2 FY2026 (ends May) | reported May 21 | Rev $13.4B | EPS $6.55 vs $5.70 🟢
💡 Consensus expects FY2026 EPS of ~$18.10, roughly aligned with the high end of company guidance ($4.5–5.0B or $16.6–18.5 EPS). The market-implied P/E of 32.2x sits above historical median and near the top of the peer range, leaving little room for error; any downward revision in estimates would likely compress the multiple.
📉 Reward/risk: 0.3:1
🏢 Business Quality: 8/10
📊 Valuation: rich — P/E of 32.2x vs. historical median 32.0x and peer band 12.9–33.6x; base-case target of $484.51 (21.2x) implies 13% downside; reverse DCF...
🔮 Catalyst: Next quarterly earnings report (expected ~Aug 2026)
💰 Entry: $484.51, stop $294.82, target $767.9
📊 Our read: AVOID. Full analysis →
https://stockduty.xyz/s/DE0611